Cancer Treatment
New data from the People's Republic of China, Japan and United Kingdom lluminates research in cancer treatment
Published in Vaccine Weekly, September 13th, 2006
Study 1: Investigators have constructed and purified an HIV-TAT-survivin (T34A) mutant.
Scientists in China report, "As a novel member of the IAP family, survivin was observed to express in the most common human cancers. Anticancer therapy targeting survivin has drawn considerable attention. This report presented firstly construction of recombinant plasmid pRSET-B-TAT-survivin (T34A), expression in Escherichia coli, purification, renaturation, and bioactivity. The cDNA encoding survivin was cloned by RTPCR from breast cancer cell...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-09-13)
More Articles from Vaccine Weekly
- Dengue Vaccine
Live attenuated tetravalent dengue vaccine was safe, effective in Thai children - Malaria Vaccine
Malaria vaccine RTS,S/AS02A is safe and immunogenic in Kenyan adults - Pneumococcal Vaccine
Cost-effectiveness of 7-valent pneumococcal conjugate vaccine was evaluated - Schistosomiasis Vaccine
Schistosoma mansoni tetraspanins protect against schistosomiasis - Vector Development
Dendritic cationic lipids with charged headgroups provide efficient gene delivery - Adrenocortical Cancer
Adrenocortical carcinoma immunotherapy elicits angiogenic stability but not clinical improvement - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
